Zydus Cadila on Thursday said it is seeking permission from Drugs Controller General of India (DCGI) to initiate human clinical trials for monoclonal antibodies cocktail for treatment of COVID-19.
from IndiaTV India: Google News Feed https://ift.tt/3yHpXKk
Comments
Post a Comment